The role of master regulators in the metabolic/transcriptional coupling in breast carcinomas

PLoS ONE

Volumn 7, Issue 8, 2012, Pages

  Baca López, Karol ^a,b   Mayorga, Miguel ^b   Hidalgo Miranda, Alfredo ^a   Gutiérrez Nájera, Nora ^a   Hernández Lemus, Enrique ^a,c  

^a INSTITUTO NACIONAL DE MEDICINA GENÓMICA   (Mexico)

^b UNIVERSIDAD AUTÓNOMA DEL ESTADO DE MÉXICO   (Mexico)

^c UNIVERSIDAD NACIONAL AUTÓNOMA DE MÉXICO   (Mexico)

Author keywords

[No Author keywords available]

Indexed keywords

TRANSCRIPTION FACTOR; TRANSCRIPTION FACTOR MEF2C; UNCLASSIFIED DRUG;

ARTICLE; BREAST CARCINOMA; CDC25A GENE; CDC25C GENE; CELL CYCLE ARREST; CHOLESTEROL SYNTHESIS; COPY NUMBER VARIATION; ERK5 GENE; GENE AMPLIFICATION; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; GENETIC ANALYSIS; GENETIC LINKAGE; HUMAN; MEF2C GENE; MNDA GENE; ONCOGENE; P38 GENE; PHENOTYPE; PHYSICAL CHEMISTRY; POU2AF1 GENE; PRKAB2 GENE; PTK6 GENE; RASGRP2 GENE; ROCK1 GENE; S6K GENE; SEQUENCE HOMOLOGY; SIGNAL TRANSDUCTION; SMAD2 GENE; SMAD3 GENE; TGF BETA GENE; THERMODYNAMICS; TRANSCRIPTION REGULATION;

ALGORITHMS; BREAST NEOPLASMS; CARCINOMA; FEMALE; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION, NEOPLASTIC; GENE REGULATORY NETWORKS; GENOME, HUMAN; GENOMICS; HUMANS; MODELS, GENETIC; MODELS, STATISTICAL; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; PHENOTYPE; THERMODYNAMICS; TRANSCRIPTION, GENETIC;

EID: 84865414319     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0042678     Document Type: Article

References (81)

1. Tennant DA, Durn RV, Gottlieb E, (2010) Targeting metabolic transformation for cancer therapy,. Nature Reviews Cancer 10, 4: 267-77.
2. Geschwind JF, Georgiades CS, Ko YH, Pedersen PL, (2004) Recently elucidated energy catabolism pathways provide opportunities for novel treatments in hepatocellular carcinoma,. Expert Reviews of Anticancer Therapy 4, 3: 449-57.
3. Bhardwaj V, Rizvi N, Lai MB, Lai JC, Bhushan A, (2010) Glycolytic enzyme inhibitors affect pancreatic cancer survival by modulating its signaling and energetics,. Anticancer Research 30, 3: 743-9.
4. Dennison JB, Balakrishnan K, Gandhi V, (2009) Preclinical activity of 8-chloroadenosine with mantle cell lymphoma: roles of energy depletion and inhibition of DNA and RNA synthesis,. British Journal of Haematology 147, 3: 297-307.
5. Wallace DC, Fan W, Procaccio V, (2010) Mitochondrial energetics and therapeutics,. Annual Re-views of Pathology 5: 297-348.
6. Wallace DC, Fan W, (2010) Energetics, epigenetics, mitochondrial genetics,. Mitochondrion 10, 1: 12-31.
7. Galant NJ, Wang H, Lee DR, Mucsi Z, Setiadi DH, et al. (2009) Thermodynamic role of glutathione oxidation by peroxide and peroxybicarbonate in the prevention of Alzheimer's disease and cancer,. Journal of Physical Chemistry A 113, 32: 9138-49.
8. Tonon G, (2008) From oncogene to network addiction: the new frontier of cancer genomics and therapeutics,. Future Oncology 4, 4: 569-77.
9. Sethi JK, Vidal-Puig A, (2010) Wnt signalling and the control of cellular metabolism,. Biochemical Journal 427,1: 1-17.
10. Hernández-Lemus E, Velázquez-Fernández D, Estrada-Gil JK, Silva-Zolezzi I, Herrera-Hernández MF, et al. (2009) Information Theoretical Methods to Deconvolute Genetic Regulatory Networks applied to Thyroid Neoplasms,. Physica A 388: 5057-5069.
11. Kong YC, Wei WZ, Tomer Y, (2010) Opportunistic autoimmune disorders: from immunotherapy to immune dysregulation,. Annals of the New York Academy of Sciences 1183: 222-36.
12. Piulats J, Tarrason G, (2001) E2F transcription factors and cancer,. Clinical and Translational Oncology 3,5: 241-9.
13. Thompson MR, Xu D, Williams BR, (2009) ATF3 transcription factor and its emerging roles in immunity and cancer,. Journal of Molecular Medicine 87, 11: 1053-1060.
14. Beger M, (2004) Expression pattern of AP-2 transcription factors in cervical cancer cells and analysis of their influence on human papillomavirus oncogene transcription,. Journal of Molecular Medicine 79, 5-6: 314-320.
15. Shen Q, Brown PH, (2003) Novel Agents for the Prevention of Breast Cancer: Targeting Tran-scription Factors and Signal Transduction Pathways,. Journal of Mammary Gland Biology and Neoplasia 8,1: 45-73.
16. Baca-López K, Hernández-Lemus E, Mayorga M, (2009) Information-theoretical analysis of gene expression to infer transcriptional interactions,. Revista Mexicana de Física 55, 6: 456-466.
17. Bolstad BM, Irizarry RA, Astrand M, Speed TP, (2003) A Comparison of Normalization Methods for High Density Oligonucleotide Array Data Based on Bias and Variance,. Bioinformatics 19, 2: 185-193.
18. Smyth G, (2004) Linear models and empirical bayes methods for assessing differential expression in microarray experiments,. Statistical Applications in Genetics and Molecular Biology 3: 3.
19. Hernández-Lemus E (2010) Non-equilibrium of transcriptional bursts, New Trends in Statistical Physics: Festschrift in honor of Leopoldo García-Colín's 80 th Birthday, Macáas, A., Dagdug, L. (eds.), World Scientifi.
20. Hernández-Lemus E, (2009) Non-Equilibrium Thermodynamics of Gene Expression and Transcrip-tional Regulation,. Journal of Non-equilibrium Thermodynamics 34, 4: 371-394.
21. Reguera D, Rubí JM, Vilar JMG, (2005) The mesoscopic dynamics of thermodynamic systems,. J Phys Chem B 109: 21502-21515.
22. Carlon E, Hein T, (2006) Thermodynamics of RNA/DNA hybridization in high density oligonu-cleotide arrays,. Physica A 362: 433-449.
23. Lu ZJ, Matthews DH, (2008) Effint siRNA selection using hybridization thermodynamics,. Nu-cleic Acids Research 36, 2: 640-647.
24. Hekstra D, Taussig AR, Magnasco M, Naef F, (2003) Absolute mRNA concentrations from sequence-specific calibration of oligonucleotide arrays,. Nucleic Acids Research 31, 7: 1962-1968.
25. Hernández-Lemus E, Correa-Rodríguez MD, (2011) Non-equilibrium hyperbolic transport in tran-scriptional regulation,. PLoS ONE 6, 7: e21558 http://dx.plos.org/10.1371/journal.pone.0021558.
26. García-Colín LS, Rodríguez RF, López de Haro M, Jou D, Pérez García C, (1985) Generalized hydrodynamics and extended irreversible thermodynamics,. Physical Review A 31: 2502-2508.
27. Chen M, Eu BC, (1993) On the integrability of differential forms related to nonequilibrium entropy and irreversible thermodynamics,. Journal of Mathematical Physics 34, 7: 3012-29.
28. Reactome website: an open-source, open access, manually curated and peer-reviewed pathway database. Available: http://www.reactome.org. Accessed 2012 July 17.
29. Gene Expression Omnibus website. Available: http://www.ncbi.nlm.nih.gov/geo/. Accessed 2012 July 17.
30. GPL96 protocol NCBI entry. Available: http://www.ncbi.nlm.nih.gov/projects/geo/query/acc.cgi?acc=GPL96. Accessed 2012 July 17.
31. Tan EY, Campo L, Han C, Turley H, Pezella F, et al. (2007) BNIP3 as a progression marker in primary human breast cancer; opposing functions in situ versus invasive cancer,. Clin Cancer Res 13, 2: 467-474.
32. Gene Set Enrichment Analysis website. Available: http://www.broadinstitute.org/gsea/downloads.jsp. Accessed 2012 July 17.
33. Burrus GR, Briggs JA, Briggs RC, (1992) Characterization of the human myeloid cell nuclear differentiation antigen: relationship to interferon-inducible proteins,. J Cell Biochem 48, 2: 190-202.
34. Xie J, Briggs JA, Briggs RC, (1998) Human hematopoietic cell specifinuclear protein MNDA interacts with the multifunctional transcription factor YY1 and stimulates YY1 DNA binding,. J Cell Biochem 70, 4: 489506.
35. Pittman AM, Webb E, Carvajal-Carmona L, Howarth K, Di Bernardo MC, et al. (2008) Re-finement of the basis and impact of common 11q23.1 variation to the risk of developing colorectal cancer,. Human Molecular Genetics 17, 23: 3720-3727.
36. Duan H, Xiang H, Ma L, Boxer LM, (2008) Functional long-range interactions of the IgH 3′ enhancers with the bcl-2 promoter region in t(14;18) lymphoma cells,. Oncogene 27, 53: 6720-8.
37. Zhao C, Inoue J, Imoto I, Otsuki T, Iida S, et al. (2008) POU2AF1, an amplifition target at 11q23, promotes growth of multiple myeloma cells by directly regulating expression of a B-cell maturation factor, TNFRSF17,. Oncogene 27, 1: 63-75.
38. Ostrander JH, Daniel AR, Lofgren K, Kleer CG, Lange CA, (2007) Breast tumor kinase (protein tyrosine kinase 6) regulates heregulin-induced activation of ERK5 and p38 MAP kinases in breast cancer cells,. Cancer Research 67, 9: 199-20.
39. Schuetz SC, Bonin M, Clare SE, Nieselt K, Sotlar K, et al. (2006) Progression-Specific Genes Identified by Expression Profiling of Matched Ductal Carcinomas In situ and Invasive Breast Tu-mors, Combining Laser Capture Microdissection and Oligonucleotide Microarray Analysis,. Cancer Research 66, 10: 5278-5286.
40. Matsuura I, Lai CY, Chiang KN, (2010) Functional interaction between Smad3 and S100A4 (metastatin-1) for TGF-beta-mediated cancer cell invasiveness,. Biochemical Journal 426, 3: 327-35.
41. Petersen M, Pardali E, van der Horst G, Cheung H, van den Hoogen C, et al. (2009) Smad2 and Smad3 have opposing roles in breast cancer bone metastasis by differentially affecting tumor angiogenesis,. Oncogene 29: 1351-1361.
42. Margolin AA, Nemenman I, Basso K, Wiggins C, Stolovitzky G, et al. (2006) ARACNe: An Algorithm for the Reconstruction of Gene Regulatory Networks in a Mammalian Cellular Context,. BMC Bioinformatics 7 (Suppl I) (): S7 doi:10.1186/1471-2105-7-S1-S7.
43. Álvarez-Buylla ER, Pelaz S, Liljegren SJ, Gold SE, Burgeff C, et al. (2000) An ancestral MADS-box gene duplication occurred before the divergence of plants and animals,. Proc Natl Acad Sci U S A 97, 10: 5328-33.
44. BLAST website. Available: http://www.ncbi.nlm.nih.gov/Structure/cdd/wrpsb.cgi. Accessed 2012 July 17.
45. Chávez Montes RA, Huerta-Verde AJ, Coello G, Hernández-Lemus E, Álvarez-Buylla ER Ara- bidopsis thaliana root transcriptional interactions database. Available: http://132.248.224.66.
46. Yilmaz S, Sancar A, Kemp MG, (2011) Multiple ATR-Chk1 Pathway Proteins Preferentially As-sociate with Checkpoint-Inducing DNA Substrates,. PLoS ONE 6 (7) (): e22986.
47. Cotta-Ramusino C, McDonald ER, Hurov K, Sowa ME, Harper JW, et al. (2011) A DNA damage response screen identifies RHINO, a 9-1-1 and TopBP1 interacting protein required for ATR signaling,. Science 332 (6035) (): 1313-7.
48. Merry C, Fu K, Wang J, Yeh IJ, Zhang Y, (2010) Targeting the checkpoint kinase Chk1 in cancer therapy,. Cell Cycle 9 (2) (): 279-83.
49. Peasland A, Wang LZ, Rowling E, Kyle S, Chen T, et al. (2011) Identification and evaluation of a potent novel ATR inhibitor, NU6027, in breast and ovarian cancer cell lines,. Br J Cancer 105 (3) (): 372-81 doi: 10.1038/bjc.2011.243.
50. Wang K, Ye Y, Xu Z, Zhang X, Hou Z, et al. (2010) Interaction between BRCA1/BRCA2 and ATM/ATR associate with breast cancer susceptibility in a Chinese Han population,. Cancer Genet Cytogenet 200 (1) (): 40-6.
51. Pedram A, Razandi M, Evinger AJ, Lee E, Levin ER, (2009) Estrogen inhibits ATR signaling to cell cycle checkpoints and DNA repair,. Mol Biol Cell 20 (14) (): 3374-89.
52. Clendening JW, Pandyra A, Boutros PC, El Ghamrasni S, Khosravi F, et al. (2010) Dysregulation of the mevalonate pathway promotes transformation,. Proc Natl Acad Sci U S A 107 (34) (): 15051-6.
53. Knight LA, Kurbacher CM, Glaysher S, Fernando A, Reichelt R, et al. (2009) Activity of meval-onate pathway inhibitors against breast and ovarian cancers in the ATP-based tumour chemosen-sitivity assay,. BMC Cancer 9: 38 doi:10.1186/1471-2407-9-38.
54. Ressler S, Mlineritsch B, Greil R, (2011) Zoledronic acid for adjuvant use in patients with breast cancer,. Expert Rev Anticancer Ther 11 (3) (): 333-49.
55. Subramanian A, Tamayo P, Mootha KV, Mukherjee S, Ebert BL, et al. (2005) Gene set enrichment analysis: A knowledge-based approach for interpreting genome-wide expression profiles,. PNAS 102, 43: 15545-15550.
56. Molecular Signature Database. Available: http://www.broadinstitute.org/gsea/msigdb/collections.jsp. Accessed 2012 July 17.
57. Schuetz CS, Bonin M, Clare SE, Nieselt K, Sotlar K, et al. (2006) Progression-Specific Genes Iden-tified by Expression Profiling of Matched Ductal Carcinomas In situ and Invasive Breast Tumors, Combining Laser Capture Microdissection and Oligonucleotide Microarray Analysis,. Cancer Res 66: 10.
58. Ostrander JH, Daniel AR, Lofgren K, Kleer CG, Lange CA, (2007) Breast Tumor Kinase (Protein Tyrosine Kinase 6) Regulates Heregulin-Induced Activation of ERK5 and p38 MAP Kinases in Breast Cancer Cells,. Cancer Res 67: 9.
59. Roy D, Calaf G, Hei TK, (2001) Profiling of Differentially Expressed Genes Induced by High Linear Energy Transfer Radiation in Breast Epithelial Cells,. Mol. Carcinog 31: 4.
60. Barcode project website. Available: http://rafalab.jhsph.edu/barcode/. Accessed 2012 July 17.
61. White MRH, Masuko M, Amet L, Elliott G, Braddock M, et al. (1995) Real-time analysis of the transcriptional regulation of Hiv and Hcmv promoters in single mammalian-cells,. J Cell Sci 108: 441455.
62. Norris AJ, Stirland JA, McFerran DW, Seymour ZC, Spiller DG, et al. (2003) Dynamic patterns of growth hormone gene transcription in individual living pituitary cells,. Mol Endoc 17: 193-202.
63. Yu J, Xiao J, Ren X, Lao K, Xie XS, (2006) Probing gene expression in live cells, one protein molecule at a time,. Science 311: 16001603.
64. Komorowski M, Finkenstadt B, Rand D, (2010) Using a single flrescent reporter gene to infer half-life of extrinsic noise and other parameters of gene expression,. Biophys J 98: 2759-2769.
65. John S, Johnson TA, Sung MH, Biddie SC, Trump S, et al. (2009) Kinetic complexity of the global response to glucocorticoid receptor action,. Endocrinology 50, 4: 1766-74.
66. Lee AW, Wang N, Hornell TM, Harding JJ, Deshpande C, et al. (2011) Human cytomegalovirus decreases constitutive transcription of MHC class II genes in mature Langerhans cells by reducing CIITA transcript levels,. Mol Immunol 48: 9-10,1160-7.
67. Salim NS, Feig AL, (2009) Isothermal Titration Calorimetry of RNA,. Methods 47,3: 198205.
68. Pawitan Y, Bjöhle J, Amler L, Borg AL, Egyhazi S, et al. (2005) Gene expression profiling spares early breast cancer patients from adjuvant therapy: derived and validated in two population-based cohorts,. Breast Cancer Res 7,6: R953-64.
69. Ivshina AV, George J, Senko O, Mow B, Putti TC, et al. (2006) Genetic reclassification of histologic grade delineates new clinical subtypes of breast cancer,. Cancer Res 66,21: 10292-301.
70. Desmedt C, Piette F, Loi S, Wang Y, Lallemand F, et al. (2007) Strong time dependence of the 76-gene prognostic signature for node-negative breast cancer patients in the TRANSBIG multicenter independent validation series,. Clin Cancer Res 13,11: 3207-14.
71. Minn AJ, Gupta GP, Siegel PM, Bos PD, Shu W, et al. (2005) Genes that mediate breast cancer metastasis to lung,. Nature 436,7050: 518-24.
72. Sotiriou C, Wirapati P, Loi S, Harris A, Fox S, et al. (2006) Gene expression profiling in breast cancer: understanding the molecular basis of histologic grade to improve prognosis,. J Natl Cancer Inst 98,4: 262-72.
73. Miller LD, Smeds J, George J, Vega VB, Vergara L, et al. (2005) An expression signature for p53 status in human breast cancer predicts mutation status, transcriptional effects, and patient survival,. Proc Natl Acad Sci 102,38: 13550-5.
74. Farmer P, Bonnefoi H, Becette V, Tubiana-Hulin M, Fumoleau P, et al. (2005) Identification of molecular apocrine breast tumours by microarray analysis,. Oncogene 24,29: 4660-71.
75. Pau Ni IB, Zakaria Z, Muhammad R, Abdullah N, Ibrahim N, et al. (2010) Gene expression patterns distinguish breast carcinomas from normal breast tissues: the Malaysian context,. Pathol Res Pract 206,4: 223-8.
76. Tripathi A, King C, de la Morenas A, Perry VK, Burke B, et al. (2008) Gene expression abnormal-ities in histologically normal breast epithelium of breast cancer patients,. Int J Cancer 122,7: 1557-66.
77. Liu R, Wang X, Chen GY, Dalerba P, Gurney A, et al. (2007) The prognostic role of a gene signature from tumorigenic breast-cancer cells,. N Engl J Med 356,3: 217-26.
78. McCall MN, Uppal K, Jaffee HA, Zilliox MJ, Irizarry RA, (2011) The Gene Expression Barcode: leveraging public data repositories to begin cataloging the human and murine transcriptomes,. Nu-cleic Acids Research 39: D1011-5.
79. EMBL Breast tumors transcriptional profiling website. Available: http://www.ebi.ac.uk/gxa/experiment/E-TABM-276/ENSG00000163563. Accessed 2012 July 17.
80. EMBL Breast carcinomas transcriptional profiling website. Available: http://www.ebi.ac.uk/gxa/experiment/E-GEOD-10780ENSG00000163563. Accessed 2012 July 17.
81. EMBL MNDA transcriptional profiling website. Available: http://www.ebi.ac.uk/gxa/gene?gid=P41218#ef=diseasestate&efv=. Accessed 2012 July 17.